Pilcher WC, Yao L, Gonzalez-Kozlova E, et al. A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma. Nature cancer. 2026. doi:10.1038/s43018-025-01072-4
Publications
Owrang D, Rad A, Alerasool M, et al. Expansion of Molecular and Clinical Aspects of EPS8L2 (DFNB106)-Associated Hearing Loss Emphasizes a Potential Therapeutic Window. Molecular neurobiology. 2026;63(1):354. doi:10.1007/s12035-025-05615-9
Kimball TN, Tack RWP, Parodi L, et al. Longitudinal Trajectories of Brain Health Risk Factors Measured by the Brain Care Score and Risk of Stroke, Dementia, and Depression. Annals of neurology. 2026. doi:10.1002/ana.78145
Fryer E, Bishop T, Campbell PT, et al. Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization Analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2026;35(1):95-108. doi:10.1158/1055-9965.EPI-25-0875
PMCID
PMC7618373
Say MG, You SS, Cai Y, et al. Bioresorbable RFID capsule for assessing medication adherence. Nature communications. 2026;17(1):52. doi:10.1038/s41467-025-67551-5
Gonzales F, Schneider C, Alexe G, et al. Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemia. Leukemia. 2026. doi:10.1038/s41375-025-02845-7
Yao M, Sun N, Linville R, et al. Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD mice. Fluids and barriers of the CNS. 2026;23(1):3. doi:10.1186/s12987-025-00756-4
Smyczynska U, Rycerz A, Kozlowska K, et al. Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations. Biomarker research. 2026;14(1):9. doi:10.1186/s40364-025-00882-z
van de Weijer MP, Bassett E, Appelbaum PS, Giangrande EJ, Matthews LJ. Imputing Parental Genotypes Through Mendelian Imputation: Ethical and Legal Considerations. Behavior genetics. 2026. doi:10.1007/s10519-025-10250-0
Lee-Yow YC, Valbuena RC, Richter CS, Chang HY, Engreitz JM. Junction-targeting designs limit the application of CRISPR-Cas13d in circular RNA perturbation studies. Nucleic acids research. 2026;54(1). doi:10.1093/nar/gkaf1447